as 11-14-2024 1:35pm EST
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.
Founded: | 1997 | Country: | United States |
Employees: | N/A | City: | COCONUT GROVE |
Market Cap: | 21.9M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 33.1K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.27 | EPS Growth: | N/A |
52 Week Low/High: | $0.85 - $2.68 | Next Earning Date: | 11-14-2024 |
Revenue: | $66,404,000 | Revenue Growth: | 498.52% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
NXPL Breaking Stock News: Dive into NXPL Ticker-Specific Updates for Smart Investing
PR Newswire
a month ago
PR Newswire
a month ago
PR Newswire
2 months ago
PR Newswire
2 months ago
Simply Wall St.
3 months ago
PR Newswire
3 months ago
PR Newswire
3 months ago
Simply Wall St.
4 months ago
The information presented on this page, "NXPL NextPlat Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.